Alterity Therapeutics Limited

A$0.27As of Sun 8 Nov 2026, 12:00 UTC
ASX:ATHHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR (22.71%)
Div yield —
ROE (54.98%)
Biotechnology
Beta (5Y) (0.03)
PE TTM —
TSR TTM (47.00%)
Mkt cap A$60.71M
ROIC (36.70%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.28
5.71%
(7.50%)
Hold 3|3|6|4|7
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
25.99%
19.83%
13.93%
0.39%
Revenue$M
6.469
6.281
6.511
6.553
(4.15%)
(5.20%)
(0.24%)
1.04%
Peers (US$41.70M)
Cap (US$)
PE
41.72M
—
Capital
TTM
5Y
10Y
Leveragex
2.123
(0.090)
(0.086)
EBIT/Intx
0.833
0.298
0.310
Own earn%
(23.17)
134.67
135.52
Sh yield%
27.49
70.23
69.57
Owners
Insiders/Inst%
8.05
75.09
Short interest%
4.47
SBC / revenue%
4.07
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
16–27
$1 testx
—
Incr. ROIC%
12